Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer

PURPOSE: Cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) is standard of care for muscle-invasive bladder cancer (MIBC). However, NAC is used in less than 20% of patients with MIBC. Our goal is to investigate factors that contribute to underutilization NAC to facili...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Investig Clin Urol
Main Authors: Carvalho, Filipe LF., Zeymo, Alexander, Egan, Jillian, Kelly, Colleen H., Zheng, Chaoyi, Lynch, John H., Hwang, Jonathan, Stamatakis, Lambros, Krasnow, Ross E., Kowalczyk, Keith J.
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Urological Association 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7329637/
https://ncbi.nlm.nih.gov/pubmed/32665995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/icu.2020.61.4.390
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados